Draig Therapeutics
Developing transformative, best-in-class neuropsychiatric therapies
$65MSeries B
Role not disclosedLoading investors…
Loading investors…
Activity from announced rounds
Developing transformative, best-in-class neuropsychiatric therapies
Develops novel multifunctional antibodies for oncology and immunology & inflammation indications
Develops medicines targeting historically undruggable protein targets in cancer